Pharmaceutical manufacturer for Sodium carboxymethylcellulose

Hercules is engaged in the development of pioneering, oral medication treatments for the management of cancer and viral infections, achieved through the inhibition of the Aryl Hydrocarbon Receptor (AhR). Hercules has verified that obstructing the Aryl Hydrocarbon Receptor has the potential to: augment the immune system's reaction to cancer diminish tumor development in various solid tumor models potentially be combined to amplify the effectiveness of other immuno-oncology medications.

Mingtai Chemical Co., Ltd., established in 1972, is a well-regarded manufacturer and supplier of high-quality excipients primarily for the pharmaceutical, food, and personal care industries. Over its five decades of operation, Mingtai has built a solid reputation globally, expanding its reach to over 80 countries and maintaining business relationships with more than 3,000 customers. The company is known for its commitment to quality, flexible service, and continuous improvement in product development and manufacturing processes.